Le Lézard
Classified in: Health
Subjects: PSF, CPG, MAT

Physician assistants gather in Niagara Falls, with sights set on expansion across Canada

As Canadians from coast to coast struggle to access health care services, Canada's PAs will meet to call on governments to make better use of the profession

NIAGARA FALLS, ON, Oct. 25, 2019 /CNW/ - More than 200 physician assistants (PAs) are gathering in Niagara Falls from October 24 to 27 to discuss some of the biggest issues in health care and to call on provincial governments to use the profession to make health care services across the country more accessible and affordable.

"Canadians are rightly fuming about hallway health care, a lack of access to health care professionals, and endless waits for emergency and surgical services," said Eric Demers, President of the Canadian Association of Physician Assistants (CAPA). "Integrating PAs in team-based care is one of the best ways we can tackle these challenges and work together to improve access, improve outcomes, and control costs."

PAs are highly skilled advanced practice professionals who work autonomously under the supervision of a licensed physician to extend productivity and allow more patients to be seen. They provide primary, acute, and specialty care in all types of clinical settings.

"PAs have been successfully integrated in the Canadian military for more than 50 years and in many provincial health systems for almost a decade," said Demers. "It's time for the remaining provinces to do right by their citizens and lift the barriers that prevent us from contributing, especially in places like British Columbia and Atlantic Canada that are crying out for help."

Last month the Nova Scotia Health Authority announced it will add PAs to its orthopaedic surgery team in an effort to lower wait times for hip and knee surgeries. But with doctor shortages leading to frequent emergency department closures in Nova Scotia and Prince Edward Island, and diminished access to primary care across many parts of Canada, it's clear that there is a widespread need for PAs.

The CAPA Conference is the largest annual event that brings more than 200 PAs together to enhance their clinical skills and discuss their role in some of the biggest issues that confront the health of Canadians. Some key conference sessions include:

Other key topics that will be addressed include opioids, medical assistance in dying, and the cannabis landscape since legalization.

Media are invited to attend sessions and interviews with presenters can be arranged in advance or during the conference. To learn more about the conference, please view the online program for details.

About the Canadian Association of Physician Assistants
The Canadian Association of Physician Assistants is the national voice of physician assistants in Canada. We support quality standards and competencies and help establish the profession within the national health care framework. Learn more: capa-acam.ca.

SOURCE Canadian Association of Physician Assistants

These press releases may also interest you

at 11:05
Aptose Biosciences Inc. released highlights from a corporate event and clinical update today held at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, FL. The event was hosted by the Aptose management team and...

at 10:25
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of JNJ-68284528 (JNJ-4528), an investigational B cell maturation antigen...

at 10:20
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced combination data from two studies and a long-term integrated analysis evaluating the use of Imbruvica® (ibrutinib) for the treatment of previously untreated patients with CLL....

at 10:10
Epizyme, Inc. , a late-stage biopharmaceutical company developing novel epigenetic therapies, today reported positive, mature data at the 2019 American Society of Hematology (ASH) Annual Meeting from its ongoing Phase 2 trial of tazemetostat, an oral...

at 09:35
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that results of the TOURMALINE-AL1 trial will be presented during an oral session at the 61st American Society of Hematology (ASH) annual meeting on Saturday, December 7, 2019...

at 09:33
Oncopeptides AB  will today present follow-up data from the pivotal Phase 2 HORIZON (OP-106) study at the ASH Annual Meeting 2019. Melflufen showed an overall response rate (ORR) of 29% and clinical benefit rate (CBR) of 37% in patients with...

News published on 25 october 2019 at 06:00 and distributed by: